.After antibody-drug conjugate (ADC) expert Seagen was actually offered to Pfizer last year for an e...
.On the heels of a stage 3 gain that stopped working to excite entrepreneurs, Ironwood Pharmaceutica...
.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is enjoying after authorizing a h...
.Welcome to this week's Chutes & Ladders, our summary of significant management hirings, firings ...
.Celebrating his firm's upsized initial public offering (IPO), Septerna chief executive officer Jeff...
.AbbVie has gone back to the resource of its antipsychotic goliath Vraylar seeking yet another smash...
.GenSight Biologics is weeks off of lacking funds. Once again. The biotech just possesses sufficient...
.Monopar Rehabs is actually recovering a drug coming from the dump of AstraZeneca's uncommon disease...
.With brand new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of analysts...
.After forming a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is actually back f...